Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
176M
-
Number of holders
-
861
-
Total 13F shares, excl. options
-
121M
-
Shares change
-
+6.22M
-
Total reported value, excl. options
-
$22B
-
Value change
-
+$1.07B
-
Put/Call ratio
-
1.91
-
Number of buys
-
438
-
Number of sells
-
-397
-
Price
-
$181.75
Significant Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q1 2021
1,056 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock, par value $0.001 per share as of Q1 2021.
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) has 861 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 121M shares
of 176M outstanding shares and own 68.97% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (14.4M shares), VANGUARD GROUP INC (11.9M shares), BlackRock Inc. (8.82M shares), BAILLIE GIFFORD & CO (7.94M shares), General Catalyst Group Management, LLC (6.71M shares), Capital World Investors (5.7M shares), Sumitomo Mitsui Trust Holdings, Inc. (4.78M shares), Nikko Asset Management Americas, Inc. (4.45M shares), BANK OF AMERICA CORP /DE/ (2.54M shares), and Discovery Value Fund (2.31M shares).
This table shows the top 861 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.